Google releases AI tool for understanding the human genome

Google has released DeepVariant, its artificial intelligence (AI) tool, capable of building a person’s genome from sequencing data.

Developed by the Google Brain team and Verily, an Alphabet subsidiary, DeepVariant identifies insertion and deletion mutations and single-base-pair mutations to build an accurate picture of an individual’s genome. Researchers collected data on high-throughput reads and full genomes from the Genome in a Bottle (GIAB) project to train a deep-learning system to accurately present data.

“The success of DeepVariant is important because it demonstrates that in genomics, deep learning can be used to automatically train systems that perform better than complicated hand-engineered systems,” said Brendan Frey, CEO of Deep Genomics.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”